Tests For Infliximab Antibodies And Infliximab Drug Level Testing

Hange

Avatud menetlus
27.06.2013 14:43 (GMT+03:00)
23.08.2013 13:00 (GMT+03:00)

Hankija

Helse Bergen HF Helse Bergen HF
Julie Rinde Julie Rinde, Innkjøpsseksjonen
Postboks 1,
5021 Bergen
Norra

Hange on lõppenud

Hanke lühikirjeldus

The Contracting Authority invites tenders for the following partial deliveries/product groups:

1.Enzyme Linked Immunosorbent Assay (ELISA) based or equivalent (non-radioactive) kit designed for determination of antibodies to infliximab in serum / plasma.

2.Enzyme Linked Immunosorbent Assay (ELISA) based or equivalent (non-radioactive) kit designed for monitoring drug levels of infliximab in serum/ plasma of patients during treatment.

Also see Part 2 – Appendix 2 – Specification for further details.

Merk: For å melde din interesse i denne kunngjøringen og motta tilleggsinformasjon vennligst besøk Doffin nettsiden http://www.doffin.no/Search/Search_Switch.aspx?ID=299033.

Hankele lisatud dokumendid

Dokumendi nimi Faili suurus
Part_1_-_Rules_for_competetive_tendering.docx 113 KB
Part_1_Appendix_A_-_Tender_Letter.docx 42 KB
Part_1_Appendix_B_-_Information_about_the_tenderer.docx 41 KB
Part_1_Appendix_C__-_HSE_declaration.docx 40 KB
Part_2_-_Draft_Contract.docx 116 KB
Part_2_Appendix_1_-_Pricing_schedule.xls 48 KB
Part_2_Appendix_2_-_Specification.xlsx 111 KB
Part_2_Appendix_3_-_Delivery_locations.xlsx 15 KB

Mercell Estonia OÜ

Mercelli gruppi kuuluv Euroopa juhtiv e-hanke keskkond vahendab infot ostjate ja tarnijate vahel.

Kontakt

Mercell Eesti kasutajatugi

+372 683 6785
Mercell Estonia OÜ | Põhja puiestee 21C, 10143 Tallinn, Eesti